Participate in Research

Study for Participants of the Skyline Clinical Trial
Protocol: STUDY00006589
Full Title
A Phase 3, Open-label Study Evaluating the Long-Term Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis
The University at Buffalo (UB) Department of Medicine is recruiting participants of the Skyline study for a follow-up study. The goal of the study is to investigate the long-term safety of a triple combination therapy for people with cystic fibrosis (CF).

Participants will be enrolled in the study for about 96 weeks with an additional 4-week follow-up period. They will complete 14 study visits over the phone and up to 12 visits in-person. During the study, they will take two tablet pills by mouth each morning. They will also complete physical exams, lab tests, and surveys. Participants will be paid for each completed study visit.
Compensation: Yes
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Kids or adults who have been diagnosed with cystic fibrosis Are participants in the Skyline Clinical Trial
Age Group: Both Adults and Children
Principal Investigator: CARLA FREDERICK
+1 716-645-4806
+1 716-323-0070
+1 716-878-7375
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions